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Background: Lung function and depression are closely related to many chronic lung diseases. 
However, few studies have evaluated this association in the general population. In this study, 
we evaluated the relationship between lung function and depression in the general population 
in Korea.
Participants and methods: Data from the Ansung–Ansan cohort, a community-based 
cohort in Korea, were used to analyze the relationships between depression and lung function 
parameters. A total of 3,321 men and women aged 40–69 years were enrolled. Spirometry 
data included the forced expiratory volume in 1 second (FEV
1
), forced vital capacity (FVC), 
and the FEV
1
/FVC ratio. Depression was defined as a score of 16 by the Beck Depression 
Inventory (BDI). A propensity score analysis was conducted with the aim of reducing the bias 
of the retrospective study.
Results: The overall prevalence of depression in the study population was 13.1% (434/3,321 
participants). Depression was significantly more prevalent in women than in men (P0.001) 
and in never smokers than in ever smokers (P0.001). The group with depression was older 
(P0.001) and had a lower average body mass index (BMI) (P=0.015) than the group with-
out depression. The FEV
1
 (P0.001), FVC (P0.001), and FEV
1
/FVC ratio (P=0.022) were 
significantly lower in the group with depression than in the group without depression. After 
adjusting for age, sex, BMI, and smoking status, the mean FEV
1
 was lower in the group with 
a high BDI score than in the group with a low BDI score (P=0.044). Using multiple linear 
regression analysis and adjusting for covariates, no statistically significant relationship between 
lung function and the BDI score was found. However, the BDI score and FEV
1
 were inversely 
related in subjects older than 50 years (P=0.023).
Conclusion: Depression is associated with decreased lung function in the general population, 
especially in adults older than 50 years.
Keywords: Beck Depression Inventory, COPD, depression, lung function
Introduction
Spirometry is the most frequently used method to assess lung function in patients with 
chronic lung disease. The forced expiratory volume in 1 second (FEV
1
) gives valu-
able information about disease severity and progression.1–3 Spirometry also provides 
standardization of lung function data, which can be compared across various studies 
of pulmonary diseases.
The prevalence of depression has been increasing worldwide,4–7 and a relation-
ship between pathophysiological processes of chronic lung disease and the degree of 
depression has been identified in previous studies.8–10 In patients with chronic lung 
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disease, symptoms of depression are inversely related to 
lung function.8 Moreover, depression is associated with a 
poor prognosis in patients with obstructive lung disease, 
conferring a greater risk of exacerbation and possibly death.9 
Depression is also directly associated with a poor quality of 
life and poor adherence to treatment, especially in patients 
with chronic lung disease.10
Similarly, patients with chronic lung disease are more 
likely to have depressive disorders. According to previ-
ous studies, the global prevalence of depression in patients 
with COPD is ~40%, whereas the prevalence of depression 
is 10% in the general population.11,12 Activities of daily 
living may be significantly impaired in patients with chronic 
lung disease, owing to chronic pain, psychological stress, fre-
quent exacerbations, and dependency on health care systems. 
Therefore, depression represents a major treatment issue in 
patients with chronic lung disease.
Although previous studies have examined the association 
between depression and lung function in patients with chronic 
lung disease, few studies have evaluated this association in 
the general population.13,14 In the previous report, restric-
tive lung function and obstructive lung function, compared 
with normal lung function, were each associated with a sig-
nificantly increased likelihood of mental health problems.13 
In another population-based study, depressive symptoms 
were associated with decreased lung function in individuals 
aged 55 years and older.14 In previous studies, however, the 
definition of depression was not based on the standardized 
scale with multiple-choice self-report inventory. In this study, 
we used a community-based cohort database to investigate 
whether the presence and severity of depression are related 
to lung function in the general population in Korea.
Participants and methods
study population
This study analyzed data from the Ansung–Ansan cohort 
database, which is a community-based, ongoing, prospective 
cohort with support from the National Genome Research 
Institute (Korea Centers for Disease Control and Prevention, 
Cheongju, Korea). This cohort is also part of the Korean 
Genome and Epidemiology Study, which investigates chronic 
disease in Korea. Detailed information regarding the study 
design and protocol has been previously published.15
Biennial surveys have been completed since 2001 by 
a population-based sample of Korean males and females 
aged 40–69 years in Ansung (a rural community) and Ansan 
(an urban community). We used data from the third survey 
(2005–2006) because this is when depression measurements 
using the Beck Depression Inventory (BDI) started being 
collected from participants. The present study assessed data 
from 7,515 eligible subjects without asthma or COPD. How-
ever, 494 participants were initially excluded because they 
lacked spirometry data and 3,700 participants were excluded 
because they lacked a BDI score. Thus, a total of 3,321 
subjects were included in the final analysis (Figure 1).
The Korean Centers for Disease Control and Prevention 
obtained written informed consent from all study participants, 
and the Institutional Review Board of Severance Hospital 
(Seoul, Korea) approved the study protocol (4-2016-0458).
spirometry
Lung function was measured by spirometry (VMAX2130; 
SensorMedics Corporation, Yorba, CA, USA). The FEV
1
, 
forced vital capacity (FVC), and FEV
1
/FVC ratio data were 
included in this analysis.
Depression assessment tool
The presence of depression was defined by the total BDI 
score. The BDI is one of the most widely used assessment 
tools of depression, evaluating a patient’s emotional, cogni-
tive, motivational, and physiological status. The BDI consists 
of 21 self-reporting items, and the score ranges from 0 to 63 
with higher scores reflecting greater levels of depression.
The BDI was developed in 196116 and first translated into 
Korean by Hahn in 1986.17 There are many opinions regard-
ing the most appropriate cutoff points for BDI scores. In the 
West, a score of 15 is generally considered to indicate 
depression. However, cutoff points from 16 to 21 may be 
more appropriate in other populations, including Koreans, 
as research has shown that the average BDI score is higher 
in these populations than in Westerners.18
HOLJLEOHVXEMHFWVZLWKRXWDVWKPDRU&23'
SDUWLFLSDQWV
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Figure 1 Flow chart of patient selection for the study.
Abbreviation: BDI, Beck Depression Inventory.
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In the present study, a BDI cutoff score of 16 was used 
to indicate depression since this cutoff has been widely used 
in previous studies of Koreans.18–20
statistical analyses
Categorical variables were analyzed using Pearson’s chi-
squared test, and continuous variables were analyzed using 
one-way analysis of variance. Analysis of covariance was 
used to estimate the adjusted means of continuous variables 
(FEV
1
, FVC, and FEV
1
/FVC ratio), taking into account 
independent variables (age, sex, body mass index [BMI], 
smoking, and BDI score). In the comparison of adjusted 
means of the FEV
1
, FVC, and FEV
1
/FVC ratio, adjustment 
factors included age, sex, BMI, smoking status, and BDI 
score. Additionally, multivariate linear regression analysis 
was performed to investigate the relationship between BDI 
scores and lung function, adjusting for age, sex, BMI, and 
smoking status. In all analyses, P0.05 (two tailed) was 
considered statistically significant. Correction for multiple 
comparisons was calculated using Bonferroni correction. 
SPSS software (ver 23.0; IBM Corporation, Armonk, NY, 
USA) was used for all statistical analyses.
Propensity score matching
A propensity score analysis was conducted with the aim of 
reducing the bias of the retrospective study. The propensity 
scores included the following variables: age, sex, BMI, and 
smoking status. A propensity score difference of 0.10 was 
adopted as the maximum caliper width for matching without 
depression and depression groups. Finally, 372 matched 
patients from each group were included in the analysis.
Results
Baseline characteristics of the study 
population
A total of 3,321 subjects were included in this study, and 
the baseline characteristics of the subjects are summarized 
in Table 1. The average age of the study participants was 
Table 1 Baseline characteristics of the study population (n=3,321)
Variable Total 
(N=3,321)
Before propensity score matching 
(n=3,321)
After propensity score matching  
(n=744)
Without 
depression 
(n=2,887)
Depression 
(n=434)
P-value Without 
depression 
(n=372)
Depression 
(n=372)
P-value
BDI score 7.9±6.8 5.9±4.1 21.6±5.7 0.001 6.1±4.3 21.7±5.8 0.001
age (years) 52.4±7.3 52.0±7.1 54.7±8.3 0.001 55.2±8.2 54.7±8.3 0.463
sex, male, n (%) 1,740 (52.4) 1,567 (54.3) 173 (39.9) 0.001 154 (41.5) 148 (39.9) 0.662
BMI (kg/m2) 24.5±2.7 24.5±2.7 24.2±2.8 0.015 24.4±2.7 24.2±2.5 0.213
smoking (baseline) 0.001 0.385
never smoker 1,947 (58.6) 1,663 (57.6) 284 (65.4) 234 (62.9) 243 (65.4)
Former smoker 779 (23.5) 716 (24.8) 63 (14.5) 67 (18.0) 54 (14.5)
Current smoker 594 (17.9) 507 (17.6) 87 (20.0) 71 (19.1) 75 (20.2)
Pack-years of smoking 23.2±16.4 22.6±16.0 27.6±18.9 0.003 24.0±15.9 27.6±18.9 0.073
Occupation 0.001 0.052
White collar joba 475 (14.3) 425 (14.8) 43 (7.4) 42 (11.3) 35 (9.4)
Blue collar jobb or 
unemployed
2,857 (86.0) 2,455 (85.2) 402 (92.6) 330 (88.7) 337 (90.6)
Marriage 0.212 0.551
singlec 220 (6.6) 181 (6.3) 39 (9.0) 24 (6.5) 33 (9.0)
Married 3,101 (93.4) 2,706 (93.7) 395 (91.0) 348 (93.5) 339 (91.0)
Underlying diseases
hypertension 394 (11.9) 334 (11.6) 60 (13.8) 0.176 51 (13.8) 51 (13.8) 1.000
Diabetes mellitus 181 (5.5) 153 (5.3) 28 (6.5) 0.324 23 (6.2) 24 (6.5) 0.889
Cardiovascular disease 16 (0.5) 14 (0.5) 2 (0.5) 0.946 3 (0.9) 2 (0.5) 0.413
lung function
FeV1 (l) 2.98±0.65 3.01±0.64 2.76±0.63 0.001 2.65±0.63 2.84±0.62 0.039
FVC (l) 3.77±0.82 3.80±0.82 3.53±0.83 0.001 3.62±0.82 3.58±0.80 0.659
FeV1/FVC 79.4±6.1 79.5±6.0 78.8±6.7 0.022 79.3±6.4 78.8±6.8 0.297
Notes: Data are presented as number (%) or the mean ± standard deviation. aWhite collar job includes administrators, experts, and office workers. bBlue collar job includes 
annual workers such as farmers, fishermen, and other manual workers. csingle condition includes divorced, separated, or never married subjects.
Abbreviations: BDI, Beck Depression Inventory; BMI, body mass index; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity.
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52.4 years, and 52.4% of study population was male. The 
overall prevalence of depression was 13.1% (434/3,321 
participants), and the mean BDI score was 7.9.
Using the BDI score, we classified all subjects into the 
following two groups: those with depression and those 
without depression. There were statistically significant 
differences in age, sex, BMI, smoking status, pack-years 
of smoking, FEV
1
, FVC, and FEV
1
/FVC ratio between the 
two groups. Depression was significantly more prevalent 
in women than in men (P0.001) and in never smokers 
than in ever smokers (P0.001). The group with depres-
sion was older (54.7 vs 52.0 years; P0.001) and had a 
lower mean BMI (24.2 vs 24.5 kg/m2; P=0.015) and a large 
proportion was unemployed or had a blue collar job than 
the group without depression. Additionally, the FEV
1
 (2.76 
vs 3.01 L; P0.001), FVC (3.53 vs 3.80 L; P0.001), and 
FEV
1
/FVC ratio (78.8 vs 79.5%; P=0.022) were significantly 
lower in the group with depression than in the group without 
depression.
After propensity score matching analysis, most variables 
were balanced between groups, but FEV
1
 was lower in the 
group with depression than in the group without depression 
(P=0.039).
relationship between lung function and 
BDI score, adjusted for age, sex, BMI, 
and smoking
Table 2 displays the adjusted mean FEV
1
, FVC, and FEV
1
/
FVC ratio according to the BDI score after adjusting for age, 
sex, BMI, and smoking status. The mean FEV
1
 was lower 
in the group with a high BDI score than in the group with 
a low BDI score (2.94 vs 2.99 L; P=0.044); however, there 
was no statistically significant difference in the FVC (3.74 
vs 3.77 L; P=0.327) or FEV
1
/FVC ratio (78.9 vs 79.5%; 
P=0.058) between the two groups. The results were similar 
when propensity score was adjusted.
adjusted estimates of BDI score 
associated with lung function
Table 3 shows the regression-adjusted estimates of BDI 
scores associated with lung function using multiple linear 
regression. After adjusting for age, sex, BMI, and smoking 
status, no statistically significant relationship between lung 
function and BDI scores was found. However, after dividing 
subjects based on the median age of 50 years, the BDI score 
and FEV
1
 were inversely related in the group older than 
50 years (−0.003 L; P=0.046). A similar relationship was 
found between the FVC and BDI score in the group older 
than 50 years; however, this difference was not statistically 
significant (−0.003 L; P=0.103). After propensity score was 
adjusted, the trend of results was similar.
Discussion
In this study, the results imply linkages between depression 
and lung function among the general population in Korea. 
A higher BDI score was associated with a lower FEV
1
 after 
adjusting for age, sex, BMI, and smoking status. Furthermore, 
these results show that the severity of depression is related 
to the FEV
1
, especially in adults older than 50 years. These 
results are noteworthy, because only a few studies have 
investigated the relationship between depression and lung 
function in the general population.
According to previous studies, the global prevalence of 
depression in patients with COPD is ~40%, whereas the prev-
alence of depression is 10% in the general population.11,12 
According to Korean epidemiologic studies, the prevalence 
of probable depression, defined by a score of 16 using the 
Center for Epidemiologic Studies Depression (CES-D) scale, 
Table 2 Mean and mean differences in FeV1, FVC, and FeV1/FVC (%) by the level of BDI score adjusted for other variables
Variable Number FEV1 (L) P-value FVC (L) P-value FEV1/FVC (%) P-value
Mean 
(SE)
Mean difference 
(SE)
Mean 
(SE)
Mean difference 
(SE)
Mean 
(SE)
Mean difference 
(SE)
Before propensity score matching (n=3,321)
BDI score 0.044 0.327 0.058
0–15 2,887 2.99 (0.01) reference 3.77 (0.01) reference 79.5 (0.1) reference
16–63 434 2.94 (0.02) 0.05 (0.02) 3.74 (0.25) 0.03 (0.02) 78.9 (0.2) 0.6 (0.2)
after propensity score matching (n=744)
BDI score 0.043 0.562 0.122
0–15 2,887 2.82 (0.02) reference 3.55 (0.01) reference 79.4 (0.1) reference
16–63 434 2.76 (0.02) 0.05 (0.03) 3.53 (0.25) 0.03 (0.02) 78.8 (0.2) 0.6 (0.4)
Notes: Data are presented as adjusted mean (se) and mean difference (se) unless otherwise indicated. FeV1 and FVC were adjusted for age, sex, BMI, and smoking status. 
FeV1/FVC (%) was not adjusted for age, sex, and smoking status.
Abbreviations: BDI, Beck Depression Inventory; BMI, body mass index; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; se, standard error.
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was 25.3%–38.9% and the prevalence of definite depression 
(a CES-D score of 25) was 8.7%–21.2%.21 Notably, the 
overall prevalence of depression found in the present study 
(13.1%) is within the range found in previous studies.
There are many assessment tools for depression, includ-
ing the CES-D scale, Hamilton Depression Rating Scale, 
Montgomery–Asberg Depression Rating Scale, Geriatric 
Depression Scale, and Patient Health Questionnaire-9.18 
Here, we used the BDI because it has an established reli-
ability and validity in a variety of different population groups 
and it has a high sensitivity and specificity for diagnosing 
depressive symptoms.22–24 Moreover, the BDI is considered 
one of the most widely used self-reporting assessment tools 
for the severity of depression. In this study, we used a BDI 
cutoff score of 16, which has been previously used to indicate 
depression in studies of Koreans.18–20
The association between COPD and depression has 
been reported in several previous studies. The presence of 
depression is associated with worse clinical outcomes in 
COPD patients, as well as increased morbidity, mortality, 
disability, and health care expenditure.25–27 The prevalence of 
depression in COPD patients varies widely between studies, 
depending on the sampling methodology and the degree 
of illness severity used in the assessment of depression.25 
The prevalence of depression has been reported to range 
from 10% to 42% in patients with stable COPD and from 
10% to 86% in patients with acute COPD exacerbation.25,28,29 
Furthermore, growing evidence suggests that the relationship 
between depression and COPD is bidirectional, meaning that 
depression adversely impacts the prognosis in COPD patients 
and the presence of COPD increases the risk of developing 
depression.9,30,31
Despite many previous reports about the relationship 
between COPD and depression, few studies have evaluated 
the correlation between lung function and depression in the 
general population.13,14 In a study based on a general popula-
tion aged 25–74 years in the USA, obstructive lung function 
was associated with significantly lower overall well-being 
and restrictive lung function was associated with significantly 
lower overall well-being, general health, vitality, and self-
control, as well as with higher depression subscale scores.13 
In that study, the General Well-Being (GWB) scale was 
used, which is a well-validated measure of psychological 
status and well-being.13 Although the GWB score is a widely 
accepted representation of mental health, it does not directly 
assess psychopathology. The BDI, which was used in our 
study, is considered to be more appropriate for assessing 
depression than the GWB scale. However, the study by 
Lu et al14 demonstrated an association between depressive 
symptoms and obstructive lung function parameters, such 
as the FEV
1
 and FEV
1
/FVC ratio, in older adults within the 
general population. In line with those results, the present 
study also found that depression was associated with a lower 
FEV
1
 in the general population, particularly in adults older 
than 50 years. However, the study by Lu et al only included 
older subjects, whereas the present study included subjects 
across a wider age range.
The mechanisms underlying the association between 
depression and lung function remain unclear; however, there 
are several possible mechanisms to consider. For example, 
Table 3 adjusted estimates of BDI for lung function according to multiple linear regression analysis
Dependent 
parameters
Before propensity score matching (n=3,321) After propensity score matching (n=744)
Estimated 
BDI score
Standard 
error
P-value Estimated 
BDI score
Standard 
error
P-value
all
FeV1 (l) −0.001 0.001 0.472 −0.002 0.001 0.107
FVC (l) −0.001 0.001 0.732 −0.001 0.001 0.455
FeV1/FVC (%) −0.009 0.014 0.844 −0.026 0.021 0.217
age 50 years
FeV1 (l) 0.001 0.002 0.639 0.001 0.003 0.682
FVC (l) 0.001 0.002 0.476 0.003 0.003 0.298
FeV1/FVC (%) −0.012 0.020 0.561 −0.031 0.033 0.341
age 50 years
FeV1 (l) −0.003 0.001 0.046 −0.005 0.002 0.022
FVC (l) −0.003 −0.002 0.103 −0.004 0.002 0.150
FeV1/FVC (%) −0.016 0.020 0.864 −0.032 0.029 0.273 
Notes: Data are presented as adjusted mean (se) and mean difference (se) unless otherwise indicated. FeV1 and FVC were adjusted for age, sex, BMI, and smoking status. 
FeV1/FVC (%) was not adjusted for age, sex, and smoking status.
Abbreviations: BDI, Beck Depression Inventory; BMI, body mass index; FeV1, forced expiratory volume in 1 second; FVC, forced vital capacity; se, standard error.
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decreased lung function may be related to symptoms such as 
dyspnea, which can lead to feelings of hopelessness, reduced 
physical activity, social isolation, and a sedentary lifestyle. 
All of these factors can be associated with an increased level 
of depressive symptoms. Moreover, a previous study found 
that the relationships between depression and lung function 
appear to be partly mediated by proinflammatory cytokines 
such as interleukin-6 and C-reactive protein.14
The present study has several strengths. First, this is the 
first study to investigate the relationship between depression 
and lung function in the general population and not just in 
elderly subjects. Second, this study was based on a large 
community-based cohort and is therefore free of clinical 
selection bias from over-sampling of severe cases of diseases. 
Third, this analysis controlled for potentially confounding 
factors such as age, sex, smoking, and BMI.
The present study does have several limitations. First, it is 
difficult to establish a causal relationship in a cross-sectional 
study. Second, depression was measured by the BDI rather 
than a structured psychiatric interview. The BDI is a self-
report questionnaire, which may underestimate a person’s 
degree of depression. Furthermore, too many subjects 
(3,700/7,515 eligible subjects) were excluded because they 
lacked a BDI score. There was a possibility that those subjects 
who were affected by severe depression could not answer the 
multiple questions in BDI and lacked a BDI score. Third, the 
BDI-I that was used in the present study might be an outdated 
assessment tool. The BDI-II, which was developed in 1996 
based on the criteria of the Diagnostic and Statistical Manual 
of Mental Disorders, fourth edition,32 was first validated for 
use in Koreans in 2008 by Sung et al.33 Fourth, the informa-
tion on the use of selective serotonin reuptake inhibitors or 
other medications was not fully investigated in Ansung–
Ansan cohort study. Fifth, the data for the spirometry of 
Ansung–Ansan cohort study since 2006 have not been opened 
to the public yet. Therefore, the data analyzed in this study 
were 12 years old.
Conclusion
We found that depressive symptoms were associated with 
decreased lung function in the general population and not 
just in patients with chronic pulmonary disease. This trend 
was especially prominent in subjects older than 50 years. 
Depression is the most common mood disorder, and respira-
tory diseases, such as COPD, are among the leading causes 
of morbidity and mortality in Korea. Therefore, regular 
screening of depressive symptoms, as well as referrals to 
psychiatrists for those with signs or symptoms of a depressive 
disorder, are recommended. Future studies investigating the 
mechanisms underlying the association between depression 
and lung function may have significant public health implica-
tions in terms of both primary and secondary preventions.
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